newsfilter
← Latest News
GlobeNewswire·

vTv Therapeutics to Participate in the 38th Annual ROTH Conference

HIGH POINT, N.C., March 16, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (NASDAQ:VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral